Skip to main content
Top
Published in: Insights into Imaging 6/2018

Open Access 01-12-2018 | Pictorial Review

Imaging presentation of pancreatic neuroendocrine neoplasms

Authors: Valentina Ciaravino, Riccardo De Robertis, Paolo Tinazzi Martini, Nicolò Cardobi, Sara Cingarlini, Antonio Amodio, Luca Landoni, Paola Capelli, Mirko D’Onofrio

Published in: Insights into Imaging | Issue 6/2018

Login to get access

Abstract

Pancreatic neuroendocrine neoplasms (P-NENs) are the second most common solid pancreatic neoplasms. P-NENs have a wide range of imaging features presentations and they can be detected with typical and atypical imaging presentations. Typical and atypical appearances can be explained by pathologic correlations. P-NENs are generally hypervascular lesions, showing a typical enhancement behavior after contrast media injection during imaging methods, but they could also have different imaging features, creating some difficulty in differential diagnosis. For this reason, radiologists should be aware of different imaging presentations of these neoplasms. Radiological evaluation has a critical role in P-NENs identification, characterization, and staging of these neoplasms, especially in those cases in which surgery is the treatment of choice. The present paper shows, indicating the underlying pathologic correlations, typical and atypical presentations of NENs.

Key Points

P-NENs have a wide range of imaging features presentations, typical and atypical.
Pathology could help in better understanding the typical P-NENs appearance at imaging.
P-NENs are generally hypervascular lesions.
Radiological evaluation has a critical role in P-NENs identification and management.
Radiologists should know every type of different imaging presentation of P-NENs to better diagnose these kinds of lesions.
Literature
1.
go back to reference D’Onofrio M, Capelli P, Pederzoli P (eds) (2015) Imaging and pathology of pancreatic neoplasms. A pictorial atlas. Springer, Milan D’Onofrio M, Capelli P, Pederzoli P (eds) (2015) Imaging and pathology of pancreatic neoplasms. A pictorial atlas. Springer, Milan
2.
go back to reference Sun J (2017) Pancreatic neuroendocrine tumors. Intractable Rare Dis Res 6(1):21–28CrossRef Sun J (2017) Pancreatic neuroendocrine tumors. Intractable Rare Dis Res 6(1):21–28CrossRef
3.
go back to reference Fraenkel M, Kim MK, Faggiano A, Valk GD (2012) Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26:691–703CrossRef Fraenkel M, Kim MK, Faggiano A, Valk GD (2012) Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26:691–703CrossRef
4.
go back to reference Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15:409–427CrossRef Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15:409–427CrossRef
5.
go back to reference Procacci C, Biasiutti C, Carbognin G et al (2001) Pancreatic neoplasms and tumor-like conditions. Eur Radiol 11(S2):S167–S192 Procacci C, Biasiutti C, Carbognin G et al (2001) Pancreatic neoplasms and tumor-like conditions. Eur Radiol 11(S2):S167–S192
6.
go back to reference Dixon E, Pasieka JL (2007) Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol 19:30–35CrossRef Dixon E, Pasieka JL (2007) Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol 19:30–35CrossRef
7.
go back to reference Tamm EP, Kim EE, Ng CS (2007) Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 21:409–432CrossRef Tamm EP, Kim EE, Ng CS (2007) Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 21:409–432CrossRef
8.
go back to reference Capelli P, Martignoni G, Pedica F et al (2009) Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med 133:350–364PubMed Capelli P, Martignoni G, Pedica F et al (2009) Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med 133:350–364PubMed
9.
go back to reference Turaga KK, Kvols LK (2011) Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 61:113–132CrossRef Turaga KK, Kvols LK (2011) Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 61:113–132CrossRef
10.
go back to reference O’Grady HL, Conlon KC (2008) Pancreatic neuroendocrine tumours. Eur J Surg Oncol 34:324–332CrossRef O’Grady HL, Conlon KC (2008) Pancreatic neuroendocrine tumours. Eur J Surg Oncol 34:324–332CrossRef
11.
go back to reference Lee LS (2010) Diagnosis of pancreatic neuroendocrine tumors and the role of endoscopic ultrasound. Gastroenterol Hepatol (N Y) 6:520–522 Lee LS (2010) Diagnosis of pancreatic neuroendocrine tumors and the role of endoscopic ultrasound. Gastroenterol Hepatol (N Y) 6:520–522
12.
go back to reference Ros PR, Mortelé KJ (2001) Imaging features of pancreatic neoplasms. JBR-BTR 84:239–249PubMed Ros PR, Mortelé KJ (2001) Imaging features of pancreatic neoplasms. JBR-BTR 84:239–249PubMed
13.
go back to reference Furukawa H, Mukai K, Kosuge T et al (1998) Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients. Jpn J Clin Oncol 28:255–261CrossRef Furukawa H, Mukai K, Kosuge T et al (1998) Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients. Jpn J Clin Oncol 28:255–261CrossRef
14.
go back to reference Horton KM, Hruban RH, Yeo C, Fishman EK (2006) Multi-detector row CT of pancreatic islet cell tumors. Radiographics 26:453–464CrossRef Horton KM, Hruban RH, Yeo C, Fishman EK (2006) Multi-detector row CT of pancreatic islet cell tumors. Radiographics 26:453–464CrossRef
15.
go back to reference D’Onofrio M, Mansueto G, Falconi M, Procacci C (2004) Neuroendocrine pancreatic tumor. Abdom Imaging 29:246–258CrossRef D’Onofrio M, Mansueto G, Falconi M, Procacci C (2004) Neuroendocrine pancreatic tumor. Abdom Imaging 29:246–258CrossRef
16.
go back to reference D’Onofrio M, Mansueto G, Vasori S, Falconi M, Procacci C (2003) Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22:413–417CrossRef D’Onofrio M, Mansueto G, Vasori S, Falconi M, Procacci C (2003) Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22:413–417CrossRef
17.
go back to reference Hohl C, Schmidt T, Honnef D, Günther RW, Haage P (2007) Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging 32:150–160CrossRef Hohl C, Schmidt T, Honnef D, Günther RW, Haage P (2007) Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging 32:150–160CrossRef
18.
go back to reference Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM (2007) CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 62:371–377CrossRef Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM (2007) CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 62:371–377CrossRef
19.
go back to reference Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 21(1):43–68CrossRef Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 21(1):43–68CrossRef
20.
go back to reference McAuley G, Delaney H, Colville J et al (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60:1039–1050CrossRef McAuley G, Delaney H, Colville J et al (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60:1039–1050CrossRef
21.
go back to reference Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61CrossRef Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61CrossRef
22.
go back to reference D’Onofrio M, De Robertis R, Capelli P et al (2015) Uncommon presentations of common pancreatic neoplasms: a pictorial essay. Abdom Imaging 40:1629–1644CrossRef D’Onofrio M, De Robertis R, Capelli P et al (2015) Uncommon presentations of common pancreatic neoplasms: a pictorial essay. Abdom Imaging 40:1629–1644CrossRef
23.
go back to reference Wang Y, Chen ZE, Yaghmai V et al (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33(5):1071–1079CrossRef Wang Y, Chen ZE, Yaghmai V et al (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33(5):1071–1079CrossRef
24.
go back to reference Jang KM, Kim SH, Lee SJ, Choi D (2014) The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiol 55(2):140–148 Jang KM, Kim SH, Lee SJ, Choi D (2014) The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiol 55(2):140–148
25.
go back to reference Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef
26.
go back to reference Owen NJ, Sohaib SA, Peppercorn PD et al (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74:968–973CrossRef Owen NJ, Sohaib SA, Peppercorn PD et al (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74:968–973CrossRef
27.
go back to reference Jeon SK, Lee JM, Joo I et al (2017) Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging—retrospective cross-sectional study. Radiology 284(1):77–87CrossRef Jeon SK, Lee JM, Joo I et al (2017) Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging—retrospective cross-sectional study. Radiology 284(1):77–87CrossRef
28.
go back to reference Lewis RB, Lattin GE Jr, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30(6):1445–1464CrossRef Lewis RB, Lattin GE Jr, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30(6):1445–1464CrossRef
29.
go back to reference D’Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7(2):257–273CrossRef D’Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7(2):257–273CrossRef
30.
go back to reference Shimizu K, Shiratori K, Toki F et al (1999) Case report: nonfunctioning islet cell tumor with a unique pattern of tumor growth. Dig Dis Sci 44:547–551CrossRef Shimizu K, Shiratori K, Toki F et al (1999) Case report: nonfunctioning islet cell tumor with a unique pattern of tumor growth. Dig Dis Sci 44:547–551CrossRef
31.
go back to reference Yazawa N, Imaizumi T, Okada K et al (2011) Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case. Surg Today 41:737–740CrossRef Yazawa N, Imaizumi T, Okada K et al (2011) Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case. Surg Today 41:737–740CrossRef
32.
go back to reference Chetty R, El-Shinnawy I (2009) Intraductal pancreatic neuroendocrine tumor. Endocr Pathol 20:262–266CrossRef Chetty R, El-Shinnawy I (2009) Intraductal pancreatic neuroendocrine tumor. Endocr Pathol 20:262–266CrossRef
33.
go back to reference De Robertis R, Paiella S, Cardobi N et al (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Abdom Radiol (NY) 43(3):613–619CrossRef De Robertis R, Paiella S, Cardobi N et al (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Abdom Radiol (NY) 43(3):613–619CrossRef
34.
go back to reference Heller SJ, Ferrari AP, Carr-Locke DL, Lichtenstein DR, Van Dam J, Banks PA (1996) Pancreatic duct stricture caused by islet cell tumors. Am J Gastroenterol 91:147–149 Heller SJ, Ferrari AP, Carr-Locke DL, Lichtenstein DR, Van Dam J, Banks PA (1996) Pancreatic duct stricture caused by islet cell tumors. Am J Gastroenterol 91:147–149
35.
go back to reference Uemura K, Murakami Y, Hayashidani Y et al (2009) Main pancreatic duct obstruction due to a small nonfunctioning endocrine tumor of the pancreas. Hiroshima J Med Sci 58:45–48PubMed Uemura K, Murakami Y, Hayashidani Y et al (2009) Main pancreatic duct obstruction due to a small nonfunctioning endocrine tumor of the pancreas. Hiroshima J Med Sci 58:45–48PubMed
36.
go back to reference Kucera JN, Kucera S, Perrin SD, Caracciolo JT, Schmulewitz N, Kedar RP (2012) Cystic lesions of the pancreas: radiologic-endosonographic correlation. Radiographics 32:E283–E301 Kucera JN, Kucera S, Perrin SD, Caracciolo JT, Schmulewitz N, Kedar RP (2012) Cystic lesions of the pancreas: radiologic-endosonographic correlation. Radiographics 32:E283–E301
37.
go back to reference Bordeianou L, Vagefi PA, Sahani D et al (2008) Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg 206(6):1154–1158CrossRef Bordeianou L, Vagefi PA, Sahani D et al (2008) Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg 206(6):1154–1158CrossRef
38.
go back to reference Lesniak RJ, Hohenwalter MD, Taylor AJ (2002) Spectrum of causes of pancreatic calcifications. AJR Am J Roentgenol 178(1):79–86CrossRef Lesniak RJ, Hohenwalter MD, Taylor AJ (2002) Spectrum of causes of pancreatic calcifications. AJR Am J Roentgenol 178(1):79–86CrossRef
39.
go back to reference Poultsides GA, Huang LC, Chen Y et al (2012) Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19(7):2295–2303CrossRef Poultsides GA, Huang LC, Chen Y et al (2012) Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19(7):2295–2303CrossRef
40.
go back to reference Sahani DV, Bonaffini PA, Catalano OA, Guimaraes AR, Blake MA (2012) State-of-the-art PET/CT of the pancreas: current role and emerging indications. Radiographics 32:1133–1158 Sahani DV, Bonaffini PA, Catalano OA, Guimaraes AR, Blake MA (2012) State-of-the-art PET/CT of the pancreas: current role and emerging indications. Radiographics 32:1133–1158
41.
go back to reference Tan EH, Tan CH (2011) Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2(1):28–43CrossRef Tan EH, Tan CH (2011) Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2(1):28–43CrossRef
42.
go back to reference Kayani I, Bomanji JB, Groves A et al (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112(11):2447–2455CrossRef Kayani I, Bomanji JB, Groves A et al (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112(11):2447–2455CrossRef
43.
go back to reference Deroose CM, Hindié E, Kebebew E et al (2016) Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions. J Nucl Med 57:1949–1956CrossRef Deroose CM, Hindié E, Kebebew E et al (2016) Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions. J Nucl Med 57:1949–1956CrossRef
44.
go back to reference Krenning EP, Kwekkeboom DJ, Bakker WH et al (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731CrossRef Krenning EP, Kwekkeboom DJ, Bakker WH et al (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731CrossRef
45.
go back to reference Lee DW, Kim MK, Kim HG (2017) Diagnosis of pancreatic neuroendocrine tumors. Clin Endosc 50:537–545CrossRef Lee DW, Kim MK, Kim HG (2017) Diagnosis of pancreatic neuroendocrine tumors. Clin Endosc 50:537–545CrossRef
46.
go back to reference Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617–1626CrossRef Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617–1626CrossRef
47.
go back to reference Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J (2010) The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med 51:875–882 Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J (2010) The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med 51:875–882
48.
go back to reference Bombardieri E, Maccauro M, De Deckere E, Savelli G, Chiti A (2001) Nuclear medicine imaging of neuroendocrine tumours. Ann Oncol 12(S2):S51–S61 Bombardieri E, Maccauro M, De Deckere E, Savelli G, Chiti A (2001) Nuclear medicine imaging of neuroendocrine tumours. Ann Oncol 12(S2):S51–S61
49.
go back to reference Ichikawa T, Peterson MS, Federle MP et al (2000) Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216(1):163–171CrossRef Ichikawa T, Peterson MS, Federle MP et al (2000) Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216(1):163–171CrossRef
50.
go back to reference Nakamoto Y, Higashi T, Sakahara H et al (2000) Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities. Clin Nucl Med 25(2):115–119CrossRef Nakamoto Y, Higashi T, Sakahara H et al (2000) Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities. Clin Nucl Med 25(2):115–119CrossRef
51.
go back to reference Garin E, Le Jeune F, Devillers A et al (2009) Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med 50:858–864CrossRef Garin E, Le Jeune F, Devillers A et al (2009) Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med 50:858–864CrossRef
52.
go back to reference Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16:978–985 Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16:978–985
53.
go back to reference Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, Yu D (2008) Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics 28:1131–1145 Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, Yu D (2008) Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics 28:1131–1145
54.
go back to reference McStay MK, Maudgil D, Williams M et al (2005) Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy. Radiology 237:718–726CrossRef McStay MK, Maudgil D, Williams M et al (2005) Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy. Radiology 237:718–726CrossRef
55.
go back to reference Atwell TD, Charboneau JW, Que FG et al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409–421CrossRef Atwell TD, Charboneau JW, Que FG et al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409–421CrossRef
Metadata
Title
Imaging presentation of pancreatic neuroendocrine neoplasms
Authors
Valentina Ciaravino
Riccardo De Robertis
Paolo Tinazzi Martini
Nicolò Cardobi
Sara Cingarlini
Antonio Amodio
Luca Landoni
Paola Capelli
Mirko D’Onofrio
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 6/2018
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-018-0658-6

Other articles of this Issue 6/2018

Insights into Imaging 6/2018 Go to the issue